Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting: European Journal of Cancer

R. Depenni, M. Cossu Rocca, D. Ferrari, G. Azzarello, C. Baldessari, M. Alù, F. Nolé, C. Codecà, G. Boscolo, M. Piccininni, S. Cavalieri, P. Bossi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting: European Journal of Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences